Home ADC's in Development fields

ADC's in Development fields

World ADC 2023 London – What to Expect

ADC Review | Editorial Team

Advances in the Development of Dual-Drug Antibody Drug Conjugates

European Medicines Agency Validates Marketing Authorization Application for Trastuzumab Duocarmazine

Sacituzumab Govitecan Increases PFS for Patients With Most Common Type of Advanced Breast Cancer in Patients who have Received Prior Therapy

Preclinical Data from Magenta’s CD45-ADC Demonstrates Successful Immune Reset to Halt Disease Progression

What is Pyrrolobenzodiazepine (PBD)?

ADC Review | Editorial Team

Pyrrolobenzodiazepine (PBD) Chemical Name: Diazepinoindole; Molecular Formula: C14H14N2O3 Molecular weight: 258,27 g/mole Average mass: 181.193 Da Monoisotopic mass: 181.063995 Da Introduction Discovered in 1963, the pyrrolobenzodiazepines (PBDs) are...

ADC's in Development fields

World ADC 2023 London – What to Expect

Advances in the Development of Dual-Drug Antibody Drug Conjugates

European Medicines Agency Validates Marketing Authorization Application for Trastuzumab Duocarmazine

Sacituzumab Govitecan Increases PFS for Patients With Most Common Type of Advanced Breast Cancer in Patients who have Received Prior Therapy

Preclinical Data from Magenta’s CD45-ADC Demonstrates Successful Immune Reset to Halt Disease Progression

What is Pyrrolobenzodiazepine (PBD)?

Latest

Pfizer to Acquire Seagen for US $ 43 Billion

World ADC 2023 London – What to Expect

Researchers at Wertheim UF Scripps Institute Make Significant Advancement ADC Development

Peer Review

Advances in the Development of Dual-Drug Antibody Drug Conjugates

Recent Advances in Antibody-drug Conjugates Produced Using Chemical Conjugation Technology

Polatuzumab Vedotin in the Treatment of Patients with Previously Untreated Diffuse Large B-Cell Lymphoma...